Cancel
Maude Tessier
Chief Business Officer
@
Seismic Therapeutic
6fv4q.0l95p9h@34gphn3kk.97k
Sign up to see email
See Linkedin
Known information
- Holds a PhD from the Department of Medical Biophysics at the University of Toronto
- Earned an Honors Great Distinction BSc in Biochemistry from McGill University
- Served as Chief Business Officer of Ikena Oncology where she managed business development, legal, and corporate strategy functions
- Led the negotiation of a $1B+ strategic partnership with BMS
- Drove core financing activities resulting in over $260M in private and public capital at Ikena Oncology
- Previously worked as Executive Director, Business Development and Licensing at Merck & Co, focusing on oncology and immunology in the Boston innovation hub
- Began her career at Xanthus Pharmaceuticals, contributing to business development and program management of a Phase 3 drug candidate
- Is a co-chair of the Boston Biobreak CBO forum
- Serves as an investment advisory board member for the Brown University Biomedical Innovations to Impact Fund
- Mentors for Endless Frontier Labs
About Seismic Therapeutic
Seismic Therapeutic is a biotech company using machine learning to develop biologics for autoimmune diseases, with a focus on novel enzyme and antibody therapeutics.
Report inaccurate information
